| NVCT Market Cap History Table | ||||||||||||||||||||||||||||||
Below is a table of the NVCT market cap history going back to 11/7/2022:
Also see: NVCT Shares Outstanding History and NVCT YTD Return |
NVCT Market Cap History — Nuvectis Pharma Capitalization Over Time
As of 5/1/2026 Nuvectis Pharma has a market cap of 226.53 million. Investors often follow the NVCT market cap history to compare the size of the company over time.
This page shows NVCT market capitalization trends over time, with 14 market cap datapoints presented, dating back to 11/7/2022.
| NVCT Market Cap History Chart | |||||||||||||||||||||||||||||||
NVCT Historical Market Cap: +25.34% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||
| NVCT Stock Price Chart |
| About Nuvectis Pharma Inc |
| Nuvectis Pharma, Inc. is a clinical-stage biopharmaceutical company focused on the development of precision medicines for the treatment of serious conditions of unmet medical need in oncology. Co. is developing two drug candidates: NXP800 and NXP900. NXP800 is an oral small molecule GCN2 activator, which is in a Phase 1b clinical trial for the treatment for platinum resistant, ARID1a-mutated ovarian carcinoma and in an investigator-sponsored clinical trial for the treatment of cholangiocarcinoma. NXP800 activates the GCN2 kinase inducing inhibition of cap-dependent protein translation and activation of the integrated stress response leading to cancer cell death. We show 14 historical shares outstanding datapoints in our NVCT shares outstanding history coverage, used to compute NVCT market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing NVCT market cap history over the course of time is important for investors interested in comparing NVCT's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of NVCT versus a peer is one thing; comparing NVCT market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like NVCT can fluctuate over the course of history. With this page we aim to empower investors researching NVCT by allowing them to research the NVCT market cap history. |
| NVCT Current Stock Quote |
Quotes delayed 20 minutes  Free NVCT Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: The Importance of Market Cap | |
|
Video: The Importance of Market Cap
| NVCT Share Performance |
| Market Cap Peers |
| Nuvectis Pharma (NVCT) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
NVIV Market Cap History NVNO Market Cap History NVO Market Cap History NVOS Market Cap History NVRO Market Cap History NVST Market Cap History NVTA Market Cap History NVTR Market Cap History NVUS Market Cap History NXGL Market Cap History More Healthcare companies » |
NVCT Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
